DexCom: The End Of The Beginning Is Almost Here [Seeking Alpha]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Seeking Alpha
SummaryG7 could change the valuation dramatically.It is a risky play, especially in the short term.G7 could finally deliver affordable CGM for type 2 diabetes patients.DexCom (DXCMGOOG(NASDAQ:GOOGLhealth division Verily to integrateSource:The G7 will fully integrate Verily's technology and a completely new manufacturing process and design, which promises to deliver higher comfort, lower cost, and longer duration. Typically, CGM is used for type 1 diabetes patients who require insulin. Still, as CGM becomes more affordable, it could make sense for a greater percentage of type 2 diabetes patients to monitor their glucose via CGM.The stock presents a high-risk, high-reward profile, with the highest concentration of risk in the short term. The company could improve dramatically with the launch of the G7, which could push it to the higher end of the spectrum and reduce the risk dramatically.All you need to know about G7Approval support trials for G7 started in mid-October. It is expected t
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Market Analysis Forecasts Substantial Growth for Global Artificial Pancreas Device Systems - Projections to 2032 - Technological Innovations and Regulatory Support [Yahoo! Finance]Yahoo! Finance
- Can DexCom, Inc.'s (NASDAQ:DXCM) ROE Continue To Surpass The Industry Average? [Yahoo! Finance]Yahoo! Finance
- Brace for Pressure: DataGrail Reports Worldwide Surge in Data Privacy Requests [Yahoo! Finance]Yahoo! Finance
- DexCom, Inc. (NASDAQ: DXCM) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.MarketBeat
- Here is Why Growth Investors Should Buy DexCom (DXCM) Now [Yahoo! Finance]Yahoo! Finance
DXCM
Earnings
- 4/25/24 - Beat
DXCM
Sec Filings
- 5/2/24 - Form 4
- 4/30/24 - Form 144
- 4/25/24 - Form 10-Q
- DXCM's page on the SEC website